What laboratory tests detect pulmonary fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Pulmonary fungal infections can be detected using various laboratory tests, including serum galactomannan (GM) testing, bronchoalveolar lavage (BAL) testing with GM, serum antibody testing, and PCR-based assays.

Laboratory Tests for Pulmonary Fungal Infections

  • Serum GM testing: recommended for patients with severe immunocompromise, such as those with neutropenia or hematological malignancy, presenting with unexplained lung infiltrates suspected of invasive pulmonary aspergillosis (IPA) 1
  • BAL testing with GM: recommended for patients suspected of invasive fungal diseases, including those with a negative serum GM but strong risk factors for invasive aspergillosis or positive serum GM but confounding factors for false-positive GM results 1
  • Serum antibody testing: recommended for patients with suspected blastomycosis, specifically directed against the anti–BAD-1 (anti–Blastomyces adhesin 1) antigen 1
  • PCR-based assays: can be used in conjunction with other diagnostic tests, such as direct microscopy, histopathology, and culture, to diagnose fungal infections 1

Specific Tests for Different Fungal Infections

  • Invasive pulmonary aspergillosis (IPA): serum GM testing, BAL testing with GM, and PCR-based assays can be used for diagnosis 1
  • Blastomycosis: serum antibody testing specifically directed against the anti–BAD-1 (anti–Blastomyces adhesin 1) antigen can be used for diagnosis 1
  • Coccidioidomycosis: multiple diagnostic tests, including direct visualization and culture of sputum BAL or other biopsy material, urine and serum antigen testing, and serology (serum antibody testing), can be used for diagnosis 1
  • Mucormycosis: galactomannan detection is moderately supported for diagnosis, while 1,3-b-D-glucan testing is not recommended 1

From the Research

Laboratory Tests for Pulmonary Fungal Infections

The following laboratory tests are used to detect pulmonary fungal infections:

  • Direct microscopic examination of secretions or body fluids 2
  • Histopathologic examination of tissue biopsies 2
  • Cultures of secretions, body fluids, or ground-up tissue 2
  • Immunological tests, including serologic techniques such as immunodiffusion and complement fixation 3
  • Molecular techniques, including nucleic acid probes, mass spectrometry-based methods, nucleic acid amplification testing, and traditional and broad-range sequencing 3
  • Non-culture-based tests for the detection of galactomannan, β(1,3)-glucan, and an extracellular glycoprotein 4
  • Labeled primer polymerase chain reaction for quantitative detection and differentiation of common pulmonary fungal pathogens 5
  • Fluorescent in situ hybridization-based molecular methods for specific detection of fungal species 4
  • Detection of antibodies, antigens, or nucleic acid for diagnosis of mycoses 6
  • Search for galactomannan antigen and use of "Lateral Flow Device" for diagnosis of aspergillosis 6

Specific Tests for Common Pulmonary Fungal Pathogens

  • Aspergillus spp: galactomannan antigen detection, β(1,3)-glucan detection, and molecular tests based on PCR 4, 6
  • Fusarium spp: labeled primer polymerase chain reaction 5
  • Scedosporium spp: labeled primer polymerase chain reaction 5
  • Mucorales: labeled primer polymerase chain reaction 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis of pulmonary fungal infections.

Seminars in respiratory infections, 1988

Research

Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.